Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-008012
Filing Date
2022-04-04
Accepted
2022-04-04 17:57:30
Documents
1
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4229
  Complete submission text file 0001567619-22-008012.txt   5702
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 22804211